Diagnosing head and neck cancer requires careful examination and various tests to identify the disease early and determine the most effective treatment approach.

Who Should Undergo Diagnostics

People who notice changes in their mouth, throat, or neck that don’t go away should seek medical evaluation. Symptoms that last longer than two weeks should always prompt a visit to a healthcare provider. A sore throat that doesn’t heal, unusual lumps in the neck or mouth, or persistent pain when swallowing are all signs that diagnostic tests may be needed.^[2]

Certain individuals face higher risks and might benefit from more vigilant monitoring. People who use tobacco products, including cigarettes, cigars, or smokeless tobacco, are at increased risk. Heavy alcohol drinkers also need to be more alert to warning signs. Those who have been exposed to the human papillomavirus (HPV) may develop cancers in the throat area, particularly in the tonsils and base of the tongue. About 70% of cancers in the oropharynx are linked to HPV infection.^[2]

Anyone experiencing specific symptoms should not delay seeking medical advice. In the mouth, warning signs include white or red sores that don’t heal on the gums, tongue, or lining of the mouth. Swelling in the jaw, unusual bleeding, or persistent pain in the mouth are concerning. If dentures suddenly don’t fit properly, this could signal changes in the mouth structure.^[2]

Symptoms involving the throat can be particularly troubling. Difficulty breathing or speaking, trouble swallowing food, or the feeling that something is caught in the throat all warrant medical attention. Pain in the throat that persists, or pain and ringing in the ears without an obvious cause, should be evaluated by a doctor.^[2]

Problems with the sinuses and nasal passages may also indicate the need for diagnostic testing. Blocked sinuses that won’t clear, sinus infections that don’t respond to antibiotic treatment, and bleeding through the nose are potential warning signs. Headaches, pain and swelling around the eyes, or pain in the upper teeth can all be related to cancers in these areas.^[2]

Changes in the voice box require prompt evaluation. Pain when swallowing, persistent hoarseness, voice changes that don’t resolve, or unexplained ear pain can all signal problems in the larynx, which is the medical term for the voice box.^[2]

Classic Diagnostic Methods

Diagnosing head and neck cancer typically begins with a thorough physical examination of the head and neck area. A healthcare professional will look carefully at the mouth, throat, and neck, searching for visible abnormalities like sores, lumps, or unusual tissue changes. They may use a light and mirror to examine areas that are difficult to see, such as the back of the mouth and upper throat.^[9]

The examination includes feeling the neck for lumps or swelling. Enlarged lymph nodes—small bean-shaped structures that are part of the immune system—may indicate that cancer has spread. When head and neck cancer spreads, it most commonly moves first to the lymph nodes in the neck. The doctor will carefully palpate these areas to detect any abnormalities.^[1]

For areas that cannot be seen with a simple visual examination, doctors use specialized tools. To look inside the throat, a tiny camera attached to a thin, flexible tube may be passed down the throat. This allows the healthcare provider to see the pharynx (the throat) and larynx (voice box) clearly. The camera transmits images that help identify any suspicious areas that need further investigation.^[9]

Similarly, to examine the inside of the nose and the nasal cavity—the hollow space inside the nose—a small camera can be gently inserted through the nostrils. This procedure allows doctors to view the nasal passages and the paranasal sinuses, which are small hollow spaces in the bones surrounding the nose.^[9]

When suspicious tissue is found, a biopsy is performed. This procedure involves removing a small sample of tissue for laboratory testing. The method used depends on where the potential cancer is located. If the abnormal area is easy to reach, such as in the mouth, the doctor may use a cutting tool to remove a piece of tissue directly. This type of biopsy is relatively straightforward and can often be done during an office visit.^[9]

In other cases, a needle may be used to collect cells. During a needle biopsy, the doctor inserts a thin needle through the skin into a lump or suspicious area to draw out cells. This technique is particularly useful for examining lumps in the neck or areas that are not easily accessible by other means.^[9]

Sometimes special tools are needed to collect tissue samples from deep inside the throat or nose. These procedures may require specialized instruments that can navigate the complex anatomy of the head and neck region. Regardless of how the sample is collected, all tissue specimens are sent to a laboratory for detailed analysis.^[9]

Laboratory testing is crucial for confirming a cancer diagnosis. Trained specialists called pathologists examine the tissue under a microscope. They can determine whether the cells are cancerous and, if so, what type of cancer is present. Most head and neck cancers are squamous cell carcinomas, meaning they begin in the thin, flat cells that line the moist surfaces of the mouth, nose, and throat. About 90% of head and neck cancers fall into this category.^[8]

Additional laboratory tests provide more detailed information about the cancer. Special tests can reveal specific characteristics of the cancer cells that influence treatment decisions. For example, tests can determine whether the cancer is associated with HPV infection, which often indicates a better response to treatment.^[9]

Imaging Tests for Diagnosis

Imaging tests create detailed pictures of the inside of the body, helping doctors see the location and size of tumors. These tests are essential for understanding how far the cancer has spread and for planning treatment. Several types of imaging may be used, depending on the specific circumstances.^[9]

A computed tomography scan, commonly called a CT scan, uses X-rays taken from many angles to create cross-sectional images of the body. A computer combines these images to produce detailed pictures that show the soft tissues, blood vessels, and bones in the head and neck. CT scans are particularly good at showing the size and location of tumors and whether they have spread to nearby structures.^[9]

Magnetic resonance imaging, or MRI, uses powerful magnets and radio waves instead of X-rays to create detailed images. MRI scans are especially useful for examining soft tissues and can provide different information than CT scans. Doctors may use MRI to get a better view of certain areas or to clarify findings from other tests.^[9]

A positron emission tomography scan, known as a PET scan, works differently from CT and MRI scans. Before the scan, a small amount of radioactive sugar is injected into the body. Cancer cells, which tend to use more energy than normal cells, absorb more of this radioactive sugar. The PET scanner detects this activity and creates images that highlight areas where cancer may be present. PET scans are particularly helpful for detecting whether cancer has spread to distant parts of the body.^[9]

Sometimes imaging tests are combined. For example, a PET-CT scan merges the information from both types of scans, providing both the detailed anatomy from the CT and the metabolic information from the PET. This combination can give doctors a more complete picture of the cancer.^[9]

Staging the Cancer

Once cancer is confirmed, doctors need to determine its stage. Staging describes how large the tumor is and how far it has spread. This information is critical because it guides treatment decisions and helps predict outcomes. Staging uses the results from physical examinations, biopsies, and imaging tests.^[6]

Early-stage head and neck cancers are generally smaller and have not spread beyond their original location. These cancers are often more treatable and may require less intensive therapy. Advanced-stage cancers are larger or have spread to lymph nodes or other parts of the body. These cases typically require more aggressive treatment approaches, which might combine surgery, radiation, and medication.^[8]

About 50% of people with head and neck cancer are diagnosed when the disease is already advanced, meaning it has spread significantly. This highlights the importance of recognizing symptoms early and seeking medical evaluation promptly. When detected at an early stage, head and neck cancers are often highly curable.^[8]

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or approaches to cancer care. To participate in a clinical trial for head and neck cancer, patients must meet specific criteria. These criteria, called eligibility requirements, are designed to ensure that the trial can answer its research questions while keeping participants safe. Diagnostic tests play a central role in determining whether someone qualifies for a particular study.^[1]

The first requirement for most head and neck cancer trials is confirmed diagnosis through biopsy. The tissue sample must clearly show that cancer is present and identify the specific type. Many trials focus on squamous cell carcinomas, so the biopsy results must confirm this cell type. Other trials might study rarer forms of head and neck cancer, so the biopsy results determine which studies a patient might be eligible for.^[4]

Staging information is essential for trial eligibility. Clinical trials often target specific stages of cancer. Some trials enroll only patients with early-stage disease, while others focus on advanced cancers. Imaging tests such as CT scans, MRI scans, and PET scans provide the detailed staging information that determines whether a patient’s cancer matches the trial’s requirements.^[9]

Many trials now test whether the cancer is associated with HPV infection. HPV-positive and HPV-negative head and neck cancers behave differently and respond differently to treatment. Specialized laboratory tests on the biopsy tissue can determine HPV status. Some clinical trials enroll only HPV-positive patients, others only HPV-negative patients, and some include both groups but analyze results separately.^[13]

Blood tests are commonly required before enrolling in a clinical trial. These tests assess overall health and organ function. Doctors need to ensure that a patient’s kidneys, liver, and bone marrow are functioning well enough to handle the experimental treatment. Blood cell counts must typically be within certain ranges, as many cancer treatments affect blood cell production.^[9]

Baseline imaging serves as a reference point for measuring treatment effectiveness. Before starting an experimental therapy, detailed images of the tumor are taken. These baseline scans will be compared to follow-up images taken during and after treatment to determine whether the tumor is shrinking, staying the same, or growing. This comparison helps researchers evaluate whether the new treatment is working.^[9]

Some trials test treatments targeting specific molecular characteristics of cancer cells. In these cases, additional laboratory tests on the tumor tissue may be required. These tests look for particular genetic changes or proteins that the experimental treatment is designed to attack. Only patients whose tumors have these specific features will be eligible for such trials.^[6]

Performance status is another factor in trial eligibility. Doctors assess how well patients can perform daily activities. This is often measured using standardized scales. Clinical trials typically require patients to be well enough to tolerate the experimental treatment and participate in the study protocol, which may include frequent visits and additional tests.^[6]

Previous treatments may affect eligibility. Some trials enroll only patients who have never been treated for cancer, while others specifically seek patients whose cancer has returned after initial treatment. The diagnostic process includes documenting all previous treatments, including surgery, radiation therapy, and medications. This treatment history helps determine which trials are appropriate.^[6]

Regular monitoring during a clinical trial involves repeated diagnostic tests. Participants undergo imaging at scheduled intervals to track how the cancer responds to treatment. Blood tests are performed regularly to monitor for side effects. These ongoing assessments ensure patient safety and provide the data researchers need to evaluate the new treatment.^[6]